Anita Mathias
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Drug Transport and Resistance Mechanisms, Hepatitis B Virus Studies
Most-Cited Works
- → Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial(2020)414 cited
- → Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects(2020)262 cited
- → Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir(2015)239 cited
- → Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity(2009)207 cited
- → P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages(2005)185 cited
- → Effect of Cobicistat on Glomerular Filtration Rate in Subjects With Normal and Impaired Renal Function(2012)164 cited
- → A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C(2012)158 cited
- → Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir(2011)154 cited
- → Pharmacokinetics and Safety of Tenofovir Disoproxil Fumarate on Coadministration With Lopinavir/Ritonavir(2006)145 cited
- → Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor(2021)132 cited